Select top biotech drugs based on revenue 2019
As of today, almost all of the world's top revenue generating drugs are derived from biotechnology and are part of the so called large molecule drugs. This statistic shows some of the best-selling biotech drugs worldwide over the last years, ranked by their sales in 2019. In that year, Enbrel generated a revenue of some 6.9 billion U.S. dollars combined for companies Amgen and Pfizer, and thus was still among world's top biotech drug based on sales.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 19.2 billion U.S. dollars and 7.1 billion U.S. dollars, respectively, in 2019. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 832 dedicated biotechnology companies in 2017. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 4 1billion U.S. dollars in biotech prescription drug revenues in 2019 and is expected to reach over 48 billion U.S. dollars in 2026. One of its top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2019. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 45 billion U.S. dollars on research and development in the biotechnology sector. The United States also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 19.2 billion U.S. dollars and 7.1 billion U.S. dollars, respectively, in 2019. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 832 dedicated biotechnology companies in 2017. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 4 1billion U.S. dollars in biotech prescription drug revenues in 2019 and is expected to reach over 48 billion U.S. dollars in 2026. One of its top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2019. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 45 billion U.S. dollars on research and development in the biotechnology sector. The United States also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
